T-PA can only be effectively administered with three hours of a stroke.
<h3>What is T-PA?</h3>
This is referred to as recombinant tissue plasminogen activator and it acts as
a powerful blood thinner which is used in the treatment of stroke
experienced by individuals.
The time the drug is administered is a very important aspect in this form of
treatment. This is because the drug must be effectively administered with
three hours of a stroke. In cases, where this time frame is surpassed, then
other forms of treatment should be given to prevent bleeding in vital organs
of the body such as the brain.
Read more about Tissue plasminogen activator here brainly.com/question/9298370
Answer:
I think steroids would be the best because drugs could hurt you but steroids are less
Answer:
B. "If you will excuse me for a moment, I will let the pharmacist answer your questions about this prescription."
Explanation:
I calculated it logically
Answer:
Application or Implementation including its Clonal personality psychology for Rubeola infectious disease in something like a 6-year-old child is given below.
Explanation:
<u>Clonal Selection Theory:</u>
This hypothesis notes that lymphocytes have virulence genes preceding activation and also that spontaneous mutations throughout clonal expansion induce the formation of lymphocytes containing strong affinity antigen affiliations.
<u>Its applications are given below:</u>
- Throughout the situation of Rubeola infectious disease in such a 6-year-old boy, as shown by this hypothesis, B-cells that distinguish after such an innate immune system forming phase selection because then antioxidants formed by younger memory B cells provide significantly higher commonalities to certain antigens.
- As a result, secondary physiological systems from memory blocks have become so successful that persistent Rubeola attacks with much the same virus are prevented unless setting up.
- After the primary outbreak, genetic mutations throughout clonal selection may generate recollection B cells which could attach to implementation more effectively than those of the initial B cells.